Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Disease-causing proteins are proteins that, due to genetic mutations, misfolding, or abnormal structural changes, disrupt normal cellular functions and lead to a wide range of diseases. These proteins can either gain toxic functions or lose their normal biological activity, resulting in cellular dysfunction and disease pathology. Examples include prions, amyloidogenic proteins, oncogenic proteins, and viral oncoproteins. Therapeutic strategies target promoting correct folding, inhibiting aggregation, correcting genetic defects, and disrupting interactions with host factors.
Promoting correct folding/degradation, inhibiting aggregation/toxicity, targeting underlying genetic defects, disrupting interaction with host factors
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Disease-Causing Protein.